Navigation Links
2 Cell Transplantation studies impact dental stem cell research for therapeutic purposes

Tampa, Fla. (May. 8, 2012) Two studies appearing in a recent issue of Cell Transplantation (20:11-12), now freely available on-line at, evaluate stem cells derived from dental tissues for characteristics that may make them therapeutically useful and appropriate for transplantation purposes.

Induced pluripotent stem cells from immature dental pulp stem cells

A Brazilian and American team of researchers used human immature dental pulp stem cells (IDPSCs) as an alternative source for creating induced pluripotent stem cells (iPSCs), stem cells that can be derived from several kinds of adult tissues. According to the study authors, production of iPSCs "opens new opportunities for increased understanding of human genetic diseases and embryogenesis" and will likely have a "great impact on future drug screening and toxicology tests."

The authors note, however, that the reprogramming methodology for making iPSCs is relatively new and "needs refining" in terms of technique, efficiency and cell type choice.

The researchers report that they easily, and in a short time frame, programmed human immature dental pulp stem cells into iPSCs with the hallmarks of pluripotent stem cells.

"Human IDPSCs can be easily derived from dental pulp extracted from adult or 'baby teeth' during routine dental visits," said study lead author Dr. Patricia C.B. Beltrao-Braga of the highly ranked National Institute of Science and Technology in Stem and Cell Therapy in Ribeirao Preto, Brazil. "hIDPSCs are immunologically privileged and can be used in the absence of any immune suppression protocol and have valuable cell therapy applications, including reconstruction of large cranial defects."

Contact: Dr. Patricia C.B. Beltrao-Braga, National Institute of Science and Technology in Stem Cell and Cell Therapy, 2051 Tenente Catao Roxo St. Ribeirao Preto, Brazil.
Tel. 55 (11) 3091-7690

Citation: Beltro-Braga, P. C. B.; Pignatari, G. C.; Maiorka, P. C.; Oliveira, N. A. J.; Lizier, N. F.; Wenceslau, C. V.; Miglino, M. A.; Muotri, A. R.; Kerkis, I.
Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells. Cell Transplant. 20(11-12):1707-1719;2011.

Human dental cells analyzed for telomere length, telomerase activity

A research team from the Republic of Korea has isolated a population of stem cells derived from dental tissues of third molars and found that human dental papilla stem cells (DPaSCs; dental papilla develops into dentin and dental pulp) have biological features similar to bone marrow-derived mesenchymal stem cells (MSCs) in terms of telomere length, telomerase activity and reverse transcriptase (Rtase) activity.

MSCs, one of the most studied and clinically important populations of adult stem cells, do have shortcomings associated with their isolation and expansion from bone marrow, said study lead author Dr. Gyu-Jin Rho of the College of Veterinary Medicine, Gyeongsang National University, Republic of Korea.

"The role of telomere and telomerase are critical biological features of normal tissue stem and progenitor cells," said Dr. Rho. "Telomeres are a specialized region of repetitive DNA, and telomere shortening is related to cellular life span. Lack of telomerase indicates cellular aging. We compared the telomere length and telomerase activity in DPaSCs with those in MSCs and found that DPaSCs possessed ideal characteristics on telomere length, telomerase activity and reverse transcriptase activity, making DPaSCs suitable alternative candidates for regenerative medicine."

The researchers concluded that DPaSCs could provide a source of stem cells for tooth regeneration and repair as well as a wide range of regenerative medicine applications in humans.

"These two studies highlight the potential value of two populations of stem cells that can be derived from the immature dental pulp and papilla of teeth" said Dr. Shinn-Zong Lin, professor of Neurosurgery and superintendent at the China Medical University Hospital, Beigang, Taiwan. "Their MSC-like abilities, ease of transformation to induced pluripotent stem cells, and ease of availability make them a potentially valuable cell therapy".

Contact: Dr. Gyu-Jin Rho, DVM, PhD, College of Veterinary Medicine, Gyeongsang National University, 900 Gazwa, Jinju, GN, Republic of Korea 660-701.
Tel. (+82) 55-751-5824
Fax. (+82) 55-751-5803

Citation: Jeon, B. G.; Kang, E. J.; Mohana Kumar, B.; Maeng, G. H.; Ock, S. A.; Kwack, D. O.; Park, B. W.; Rho, G. J. Comparative Analysis of Telomere Length, Telomerase and Reverse Transcriptase Activity in Human Dental Stem Cells. Cell Transplant. 20(11-12):1693-1705; 2011.


Contact: David Eve
Cell Transplantation Center of Excellence for Aging and Brain Repair

Related biology news :

1. Gut microbiota transplantation may prevent development of diabetes and fatty liver disease
2. Neural stem progenitor cell transplantation’s potential to aid spinal cord injury tested
3. More than bacon: Genetic alterations in pig tissue may allow for human transplantation
4. New substance may allow successful transplantation of marginal livers
5. Periodontal stem cell transplantation shows promise
6. Joshua E. Neimark Memorial Travel Assistance Award winners investigate stem cell transplantation, sustainable growth, women in academia, and conservation science
7. Scientists grow human liver tissue to be used for transplantation
8. Cell Transplantation reports a success in treating end-stage liver disease
9. Cord blood cell transplantation provides improvement for severely brain-injured child
10. Japanese researchers report on liver transplantation studies using animal and iPS cells
11. New cell transplantation journal launched
Post Your Comments:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology: